Navigation Links
Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper
Date:4/14/2011

ANN ARBOR, Mich., April 14, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today top-line results from its clinical study evaluating reaZin for the dietary management of Alzheimer's disease (AD) and mild cognitive impairment (MCI). The clinical study met the primary outcome of increasing serum zinc and decreasing serum free copper. In addition, secondary outcomes of mental status as measured by three standardized cognitive tests all favored the treatment group versus the placebo group.

The clinical study data was presented today at the Annual Meeting of the American Academy of Neurology (AAN) in Honolulu, Hawaii at 2:00 p.m. (HAST)/8:00 p.m. (EDT) by Diana Pollock, M.D., Lead Principal Investigator of the study at Morton Plant Neuroscience Institute on the campus of Morton Plant Hospital. The poster titled "Clinical Trial Results of the First Controlled Clinical Trial of Zinc-Based Therapy for Alzheimer's Disease and Mild Cognitive Impairment" included findings from 42 of 57 subjects evaluable at the end of the study.  The results are as follows:

  • The treatment group showed significant reductions in serum free copper levels and elevations in serum zinc levels over the placebo group, resulting in a highly statistically significant change in the free copper to zinc ratio (-20.8%), the primary outcome of the clinical study (p < 0.0006).
    • An average net decrease in serum free copper of -6.5 microg/dL for the treatment group versus placebo group.
    • An average net increase in serum zinc of 64.6 microg/dL for the treatment group versus the placebo group.

  • Comparisons of the average changes in cognitive scores at base
    '/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PharmAthene Completes Dosing in Valortim® Phase I Clinical Trial
2. New Clinical Studies Reinforce the LAP-BAND® System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity-Related Comorbid Conditions
3. GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
4. Visual Healthcare to Support Chinese Clinical Trials
5. Preclinical Studies in Pancreatic Cancer and Melanoma Demonstrated ADI-PEG 20 Works Synergistically With Inhibitors of Autophagy
6. Spaulding Clinical Welcomes Dr. Aziz Karim, Clinical Pharmacokinetic Consultant
7. Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
8. Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
9. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
10. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
11. Boston Scientific Begins International Clinical Trial Enrollment for INNOVA™ Self-Expanding Bare-Metal Stent System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Over-the-counter healthcare ... American consumer. However, a new survey of store ... from the common cold to diabetes, can offer ... research, conducted by the Private Label Manufacturers Association, ... healthcare products, including those essential for treatment of ...
(Date:3/26/2015)... -- A new survey of health care stakeholders ... will yield improvements in health care decision-making, but ... CER in the current environment. The National Pharmaceutical ... that they view CER as important, expect it ... decision-making in the next three to five years, ...
(Date:3/26/2015)... 26, 2015  Desert Valley Medical Center, named a ... is the first U.S. hospital to deploy the ... to help clinicians prevent hospital acquired pressure ulcers. ... , is a community hospital serving some higher ... Leaf Patient Monitor in the hospital,s emergency department enables ...
Breaking Medicine Technology:Consumers can keep over-the-counter medicine affordable by using store brands 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... 2011 Sevocity, the leader in cloud-based Electronic ... achieved full certification through the Certification Commission for ... Certified® 2011 Ambulatory EHR.  Sevocity v11.1 also achieved ... level awarded by CCHIT.  The Certification Commission for ...
... -- 3SBio Inc. (NASDAQ: SSRX ) ... company focused on researching, developing, manufacturing and marketing ... Food and Drug Administration ("SFDA") has approved its ... treatment of anemia associated with chemotherapy in cancer ...
Cached Medicine Technology:Sevocity Division of Conceptual MindWorks Inc.'s Sevocity EHR Earns CCHIT 2011 Certification 23SBio Inc. Announces SFDA Approval of High-Dose EPIAO 23SBio Inc. Announces SFDA Approval of High-Dose EPIAO 33SBio Inc. Announces SFDA Approval of High-Dose EPIAO 4
(Date:3/27/2015)... Ticket Down is a reputable source for authentic tickets for ... phenomenal and highly successful live tour last year, the cast of ... again in 2015 and they will be visiting 8 cities along ... New York City at the cozy Beacon Theatre and will wrap ... , Fans of the hit show can look forward to seeing ...
(Date:3/27/2015)... Dallas, TX (PRWEB) March 27, 2015 ... Landscape – Germany” is an essential source of ... and reimbursement landscape in Germany. Germany’s increasingly elderly ... drivers of its pharmaceutical market. In 2013, the ... expected to increase at Compound Annual Growth Rate ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 While deep learning ... 2015 GPU technology conference (GTC) , the CEO of one ... and push the human lifespan well beyond the generally-agreed ceiling ... informatics company , is one of 12 companies recognized as ... other startups in the GTC Emerging Companies Summit ...
(Date:3/27/2015)... NE (PRWEB) March 27, 2015 Ticket Down ... at the CenturyLink Center in Omaha, Nebraska on Friday, ... possibility that more concert dates will be added in Omaha ... of fan demand. , The Garth Brooks World Tour is ... the latest announcement that Garth Brooks and Trisha Yearwood will ...
(Date:3/27/2015)... According to a recently published report series by ... market in Europe is in decline due to decreasing ... Price decreases are being seen across the entire orthopedic ... total European trauma device market, continued pricing pressure overall ... after year. , “Such price drops are typical ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3
... minor ... problem,- 57% are unaware that diaper rash can be accompanied by a doctor ... - 59% responded "no" or were unsure when asked if there was a connection ... between diaper rash and antibiotics, PRINCETON, N.J., June 17 Barrier,Therapeutics, Inc. (Nasdaq: ...
... 17 Gentiva Health,Services, Inc. (Nasdaq: GTIV ), ... today that it is scheduled to,present from 1:00 to ... Jefferies,2nd Annual Healthcare Conference in New York., The ... live audio web,cast, which may be accessed by visiting, ...
... bullet, to help miilions of children in developing ... -- A new compound that may lead to an ... researchers at the University of Texas Health Science Center ... important for developing countries, where diarrhea is a major ...
... UK and Philadelphia, US June 17, 2008 ... biopharmaceutical company, today announced the publication of data from ... of ulcerative colitis (UC) drug Lialda™ (mesalamine). The primary ... and tolerability of Lialda in mild-to-moderate UC patients over ...
... CHICAGO, June 17 U.S. Environmental,Protection Agency Region 5 this ... hazards from underground soil contamination in,St. Louis Park, Minn., ... and,businesses are scheduled for July 10, 2 to 4 p.m. ... High School cafeteria, 6425 W. 33rd St. EPA,s,storefront office at ...
... be released at AHIP Institute July 18-20, ... from,URAC provides answers for health plans and health ... new trends in outsourcing of,credentialing services., (Logo: ... become available during the AHIP Institute, June 18-20,in ...
Cached Medicine News:Health News:Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment 2Health News:Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment 3Health News:Vusion Baby Bottom Line Report: Many Moms Don't Know that Their Babies' Irritated Skin Could Indicate a Severe Diaper Rash that Requires Medical Treatment 4Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 2Health News:Gentiva(R) Health Services to Present June 24 at Jefferies' 2nd Annual Healthcare Conference in New York 3Health News:Inexpensive Compound Could Treat Severe Diarrhea 2Health News:Long-term safety data on Lialda published in leading GI journal 2Health News:Long-term safety data on Lialda published in leading GI journal 3Health News:St. Louis Park Vapor Systems Installation Nearly Complete; Meeting July 10 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 2Health News:New URAC Issue Brief Answers Questions About Delegated Credentialing, Transparency in Physician Tiering Programs 3
... Acid powder reagent once reconstituted offers the ... stability to help maximize laboratory productivity, minimize ... time. The proprietary technology of the Infinity ... shelf life and stability once reconstituted that ...
... Glucose Oxidase single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Glucose Oxidase reagent provides a long ...
... reagent is intended for the in ... serum. , Infinity Cholesterol powder reagent ... stability once reconstituted and convenience, but ... existing assays. The reagent is suitable ...
...
Medicine Products: